ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

CareDx Lead Sponsor for 2022 Donate Life Transplant Games

CareDx’s Mobile Health App, AlloCare, is the Official App for the Games

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced its participation and presenting sponsorship for the 2022 Donate Life Transplant Games taking place July 29 to August 3, 2022, in San Diego, California. CareDx’s transplant patient health app, AlloCare®, is the official app for the Games.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220628005490/en/

AlloCare Transplant Games (Graphic: Business Wire)

AlloCare Transplant Games (Graphic: Business Wire)

“CareDx is proud to be the lead sponsor for this year’s Donate Life Transplant Games, the largest transplant patient community event,” said Reg Seeto, CEO and President of CareDx. “It is our privilege to serve the transplant community and raise awareness about the need for donations which give patients a new lease on life.”

The biennial Donate Life Transplant Games is expected to draw over 6,000 athletes and transplant supporters from across the United States and globally. It is the largest community gathering of its kind for individuals, families, and loved ones of those who have received or given a life-saving organ, cornea, bone marrow, or tissue donation. The event includes more than 20 athletic and recreational competitions for transplant patients and living donors, 60 events for all attendees to enjoy, and celebrates transplant recipients and the donors who gave the selfless gift of life.

“A leader and innovator in the transplant space, we are honored to have CareDx’s support for this year’s Transplant Games,” said Bill Ryan, CEO of Transplant Life Foundation. “CareDx is not only advancing care for transplants but is also dedicated to helping both pre-and post-transplant patients navigate their way through their transplant journeys by providing trusted resources, education, and connecting the transplant community as a whole.”

“We are excited to be able to offer our popular AlloCare mobile patient application to all attendees to not only engage with all aspects of the Games but also learn how it can be tailored and used in a patient’s transplant journey,” said Kashif Rathore, Senior Vice President of Patient and Digital Business at CareDx. “We look forward to sharing how AlloCare helps patients navigate their pre-transplant waitlisting process and medication adherence post-transplantation.”

For more information about the 2022 Donate Life Transplant Games, download the AlloCare app by going here.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

Forward Looking Statements

This press release includes forward-looking statements related to CareDx, Inc., including statements regarding the potential benefits and results that may be achieved with CareDx’s participation and sponsorship of the 2022 Donate Life Transplant Games (the “Games”), as well as CareDx’s AlloCare transplant patient mobile health app. These forward-looking statements are based upon information that is currently available to CareDx and its current expectations, speak only as of the date hereof, and are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including risks that CareDx does not realize the expected benefits of the AlloCare transplant patient mobile health app or CareDx’s participation and sponsorship of the Games; risks that the actual participants and events in the Games fail to match the description in this press release; general economic and market factors; and other risks discussed in CareDx’s filings with the SEC, including the Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed by CareDx with the SEC on February 24, 2022, the quarterly report on Form 10-Q for the first quarter of 2022 ended on March 31, 2022 filed by CareDx with the SEC on May 5, 2022, and other reports that CareDx has filed with the SEC. Any of these may cause CareDx’s actual results, performance or achievements to differ materially and adversely from those anticipated or implied by CareDx’s forward-looking statements. CareDx expressly disclaims any obligation, except as required by law, or undertaking to update or revise any such forward-looking statements.

“CareDx is proud to be the lead sponsor for this year’s Donate Life Transplant Games, the largest transplant patient community event,” said Reg Seeto, CEO and President of CareDx. “It is our privilege to serve the transplant community and raise awareness"

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.